BIOGEN INC. Free Cash Flow 2007-2026 | BIIB
Beta
What is BIOGEN INC.'s current free cash flow?
BIOGEN INC. (BIIB) annual free cash flow for 2025 was $2.05B, a 24.65% decline from 2024. BIOGEN INC. free cash flow for the quarter ending March 31, 2026 was $594.3M.
What was BIOGEN INC.'s free cash flow in 2024?
BIOGEN INC. annual free cash flow for 2024 was $2.72B, a 114.28% increase from 2023.
What was BIOGEN INC.'s free cash flow in 2023?
BIOGEN INC. annual free cash flow for 2023 was $1.27B, a 11.03% increase from 2022.
What is BIOGEN INC.'s 5-year free cash flow CAGR?
BIOGEN INC. free cash flow grew at a compound annual growth rate (CAGR) of 11.63% from FY2020 to FY2025, going from $3.81B to $2.05B over 5 years.
Free Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-11.6%
FY2020
$3.81B
→
FY2025
$2.05B
07080910111213141516171819202122232425
5 years selected
Free Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.05B | -24.7% | 10-K |
| FY2024 | $2.72B | +114.3% | 10-K |
| FY2023 | $1.27B | +11.0% | 10-K |
| FY2022 | $1.14B | -66.2% | 10-K |
| FY2021 | $3.38B | -11.1% | 10-K |
| FY2020 | $3.81B | -42.0% | 10-K |
| FY2019 | $6.56B | +21.2% | 10-K |
| FY2018 | $5.42B | +47.1% | 10-K |
| FY2017 | $3.68B | -7.2% | 10-K |
| FY2016 | $3.97B | +21.2% | 10-K |
| FY2015 | $3.28B | +23.4% | 10-K |
| FY2014 | $2.65B | +26.5% | 10-K |
| FY2013 | $2.10B | +29.1% | 10-K |
| FY2012 | $1.63B | +7.0% | 10-K |
| FY2011 | $1.52B | +4.7% | 10-K |
| FY2010 | $1.45B | +59.6% | 10-K |
| FY2009 | $909.3M | -29.3% | 10-K |
| FY2008 | $1.29B | +75.1% | 10-K |
| FY2007 | $734.6M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →